Skip to main navigation Skip to search Skip to main content

Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))

Robert L. Coleman, Michael W. Sill, Heather A. Lankes, Amanda Nickles Fader, Neil J. Finkler, James S. Hoffman, Peter G. Rose, Gregory P. Sutton, Charles W. Drescher, D. Scott McMeekin, Wei Hu, Michael Deavers, Andrew K. Godwin, R. Katherine Alpaugh, Anil K. Sood

Research output: Contribution to journal › Comment/debate › peer-review

1   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))'. Together they form a unique fingerprint.
Sort by